No Image
Polyclonal Antibodies
Anti-MAP2 Polyclonal Antibody for WB, IF, IHC, ELISA - P11137
Item Number : CM0025492
Price varies based on specs and customizations
- Application
- WB, IF-P, IHC-P, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 200 kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | MAP2 Rabbit pAb |
| Remarks/Alias | MAP-2; MAP2A; MAP2B; MAP2C; MAP2 |
| Species | Human |
| Gene ID | 4133 (Human) |
| Immunogen | Recombinant protein: Recombinant fusion protein containing a sequence corresponding to amino acids 1510-1650 of human MAP2 (NP_002365.3). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IF-P, IHC-P, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P11137 |
| Protein Weight | 200 kDa |
| Shipping | Ice bag |
Biological Background: MAP2 Function and Localization
- MAP2 (Microtubule-associated protein 2) is a neuronal protein that exists in multiple alternatively spliced isoforms, including MAP2A, MAP2B, MAP2C, and MAP2, with a full-length molecular weight of approximately 200 kDa (UniProt: P11137).
- MAP2 binds to microtubules and is thought to stabilize them against depolymerization, contributing to a stiffening effect on the cytoskeletal network.
- The protein localizes predominantly to the cytoplasm and cytoskeleton, with prominent enrichment in dendrites of neurons, playing a critical role in maintaining dendritic structure.
- MAP2 is subject to phosphorylation, which may regulate its microtubule-binding activity, and it contains calmodulin-binding domains, suggesting calcium-mediated signaling involvement.
- The protein features repetitive sequences that likely mediate its interaction with microtubules, and it is classified as a reference proteome component, indicating its well-characterized nature.
- MAP2 has been identified in multiple proteomics studies, confirming its widespread expression in neuronal tissues.
Experimental Guidance and Technical Tips
- The immunogen corresponds to a region (aa 1510-1650) present in the longer isoforms of MAP2 (MAP2A and MAP2B); thus, the antibody may preferentially detect these high-molecular-weight forms in western blotting.
- For IF-P and IHC-P, consider using appropriate fixation and permeabilization methods to preserve microtubule structures and validate the antibody in the relevant sample system.
- Cross-reactivity with mouse and rat MAP2 has been reported; however, performance should be verified in the specific model organism.
- For western blotting, the expected band size is around 200 kDa, but smaller isoforms may also be detected depending on tissue type and alternative splicing.
- The antibody is provided as a polyclonal preparation, which may exhibit lot-to-lot variation; we recommend titrating and validating each new lot for your intended application.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to IVD raw materials, technical services, and consulting—covering every stage from concept to clinic. This anti-MAP2 polyclonal antibody supports neuroscience and cytoskeleton research applications. CamelBio offers validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and rare target raw-material sourcing to streamline your assay development needs.
Product Datasheet
Anti-MAP2 Polyclonal Antibody for WB, IF, IHC, ELISA - P11137
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!